Lecture 4 - B cells and Cancer Flashcards

1
Q

What are the hallmarks of cancer?

A

Hanahan & Weinberg’s Landmark Paper

  • Proliferation in the absence of GFs
  • Avoiding growth suppressors
  • Avoid apoptosis
  • Angiogenesis
  • Immortality
  • Metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What features of B cells are a cancer risk?

A
  • ‘Ignoring’ DNA damage
  • Avoiding apoptosis
  • Circulate around the body (metastasis)
  • Rapid proliferation
  • Long lived
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the categories of malignancies of the immune system?

A
  • Lymphomas: solid mass, lymphocytes
  • Leukaemias: lymphocytes & leukocytes, in blood
  • Myeloma: plasma cells in BM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the importance of non-Hodgkins lymphoma?

A

It is one of the most common cancers in men and women in Australia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two types of lymphomas?

What differentiates them?

A

• Hodgkins:
Presence of Reed-Sterberg cell
• Non-Hodgkins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some B cell lymphomas

A
  • Burkitt lymphoma
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Hodgkins lymphoma
  • non-Hodgkins lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the growth rates of lymhomas

A

Can be either:
• Indolent
• Aggressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the biggest risk factor for non-Hodgkins lymphoma?

A

Age:

• most people who get it are 60+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is leukaemia?

A
  • Malignancy that starts in blood forming tissue

* results in many cancerous cells entering circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some B cell leukaemias?

Whom do they affect?

A
  1. ALL: Acute lymphocytic leukaemia
    • The very young and the elderly
    • B cell precursor malignancy
  2. CLL: Chronic lymphocytic leukaemia
    • Men 50+
    • Mature B cell malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which cells can become malignant in leukaemia?

A
  • B cells
  • T cells
  • Myeloid cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is myeloma?

A

Malignancy of plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the progression of myeloma

A

MGUS: asymtpomatic pre-malignant phase in which there is clonal cell proliferation

Found in 3% of over 50’s

Progresses in less than 1% of cases per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are B cell malignancies classified?

A
Physical observation:
 • Histology, Reed-Sternberg cell
 • Patient's condition
 • Karyotype
 • Flow cytometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Reed-Sternberg cell?

A

Mysterious but diagnostic cell seen in Hodgkins lymphoma

• has markers of both myeloid and lymphoid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is an important diagnostic feature seen in multiple myeloma patients?

A

Increase concentrations and varied serum antibodies
• Clonal ‘paraproteins’
• Bruce Jones Proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are clonal paraproteins?

Where are they found?

A

Abnormal Ig produced by excess clonal proliferation of B lymphocytes

They end up in the serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are Bence Jones Proteins?

Where are they found?

A

Free light chains

In blood and urine (because they are small enough to be filtered)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are monoclonal antibodies (mAbs)?

A

These are antibodies that are all specific for a single epitope
The Abs are identical because they all come from identical B cells (i.e., they all come from the same clones)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What end organ damage occurs in multiple myeloma?

A
  1. Bone lesions and fractures
    • Increased RANKL → stimulation of osteoclasts
  2. Hypercalcemia
    • Increased break down of bone
  3. Renal insufficiency
    • So much protein in serum
  4. Anaemia
  5. Neutropaenia → infection
  6. Thrombocytopaenia → haemolytic tendency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are current treatments for non-Hodgkins lymphoma?

A
  • Chemotherapy
  • Antibodies (Rituximab)
  • Irradiation
  • Bone marrow transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the features of Bortezemib

A
"Addresses the nature of the cell"
 • A treatment for Multiple Myeloma
 • A dipeptide molecule
 • inhibits the proteasome
 • Proteasome vital part of plasma cell machinery, as they are producing such large amounts of Ig
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a proteasome?

A

A piece of cellular machinery that receives ubiquitin-marked proteins for digestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Discuss bisphosphonates

A

Treatment for MM

  • Inhibition of osteoclasts
  • Reduced bone resorption
  • Reduced growth

Addresses the symptoms of the cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Where is CD20 found?
On the surface of mature B cells
26
Describe the features of Rituximab
• Treatment for non-Hodgkins lymphoma • A monoclonal anti-CD20 Ab • Ab binds to the CD20 on mature B cells • Leads to (transient) depletion of ALL B cells (once off the drug, B cells come back slowly)
27
Where do malignant B cells congregate? What is the effect of this?
The cells crowd the bone marrow This disrupts all the other blood cells that are developing here Effect: • Cytopaenia Immunocompromise, frequent infection • Anaemia, fatigue • Thrombocytopaenia, haemorrhagic tendency
28
What is Bcl-2? Describe its normal function, and how it could cause cancer
Cell survival protein Normal function: • Binds BH3-only to prevent it from triggering apoptosis In cancer: • Involved in translocations up against the Ig gene loci • Over-expression • BH3 can never out-compete Bcl-2 t trigger apoptosis • Accumulation of cells with DNA damage
29
What is the down side of Bortezimib?
It does not selectively block proteasomes in plasma cells, rather affects all cells
30
Describe the heterogeneous nature of DLBCL
* Distinct types of the malignancy have been identified through gene expression profiling * These various types are due to the different combination of mutations that have lead to the disease Two categories: • GC type • ABC type
31
Describe ABT-263
* a treatment for B cell lymphomas * This is a drug that binds Bcl-2 (displacing BH3-only) * this allows the cell to undergo apoptosis
32
What is the most common B-cell leukaemia?
CLL: chronic lymphocytic leukaemia
33
What are some diagnostic criteria for MM?
(Multiple myeloma) • >10% clonal plasma cells on bone marrow biopsy • monoclonal antibodies in urine or serum • end organ damage
34
What are some treatments of MM?
* Bortezimib | * Bisphosphonates
35
What is DLBCL?
Diffuse large B cell lymphoma
36
Describe differences in gene expression in ABC (activated B cells) and GC B cells
ABC: most genes are switched off | GC B: most genes are switched on
37
What are the two groups of DLBCL patients? What treatment is appropriate for each respectively?
Low-clinical risk: • Better survival rates • GC type B cells • Standard therapy + Rituximab High clinical risk: • Poor survival rates • ABC type B cells • Specific enzyme inhibitors targeting hyperactive pathways
38
What is BH3-only? Describe its role in apoptosis
Molecule in the cell that triggers apoptosis Function 1. Cell stress 2. Activation of BH3 only 3. Activation of Bax and Bak 4. Cyt c loss from mitochondria 5. Formation of apoptosome 6. Activation of caspases 7. Apoptosis
39
Which molecule inhibits the action of BH3-only?
Bcl-2
40
Which drug binds Bcl-2? What is the effect of this? Which disease is it used for?
ABT-263 • Prevents Bcl-2 from inactivating BH3-only, which normally brings about apoptosis • Thus, the cancerous cell is no longer immortal Use to treat B cell lymphomas with overactive Bcl-2 such as: • CLL • Follicular lymphoma
41
What was the effect of ABT-199 in CLL patients?
Massive reduction in lymphocytes, killing all cancerous cells Platelets unaffected to a large extent
42
List the functions of myc
1. Drives proliferation • Upregulation of cyclins 2. Regulates cell growth • Enhances protein synthesis 3. Inhibits differentiation 4. Strong proto-oncogene
43
What is Bcl-6? Describe the processes it coordinates
* Inhibits DNA damage response * Inhibits differentiation * Inhibits apoptosis
44
What is the effect of myeloma cells on bone?
Malignant cells produce lots of RANK-L, which • Increases osteoclast activity Decreased OGP, which • Decreases osteoblast activity Increased resorption of bone, leaving it fragile
45
What is Bcl-x?
Cell survival protein
46
What is p53?
Detects DNA damage
47
What are cyclins?
Cell growth and proliferation regulators
48
What is the difference between oncogenes and proto-oncogenes?
Proto-oncogenes: normal cell function to do with growth and proliferation Oncogene: inappropriately expressed proto-oncogene that causes the cell to proliferation uncontrollably
49
What one of the most important proto-oncogenes? Which cancers can it lead to?
Myc | Burkitts Lymphoma, through translocation up against heavy chain locus
50
Describe the process leading to apoptosis when a cell experiences danger or damage Which molecules can inhibit this?
``` → Damage 1. BH3-only activated 2. Bax and Bak activation 3. Mitochondria release Cyt. c (Bax and Bak punch holes in mito membrane) 4. Formation of apoptosome 5. Activation of cytoplasmic caspases 6. Digestion of cell (apoptosis) ``` Bcl-2 can block BH3-only
51
Which mutation is commonly seen in Follicular lymphoma and CLL?
Over-expression of Bcl-2
52
Which molecule is vital for GC formation, as it inhibits apoptosis due to DNA damage in developing B cells?
Bcl-6
53
What is the relationship between Bcl-6 and p53?
Bcl-6 inhibits p53's action of bringing about apoptosis
54
Which cancers commonly have Bcl-6 translocation?
DLBCL
55
What happens to Bcl-6 after CD40 signalling?
Down regulated so that the following can occur: * Selection of high affinity Ig * Elimination of DNA damaged cells, or those with low affinity Ig through apoptosis
56
How may Bcl-6 be turned into an oncogene?
1. Translocation • Up against Ig gene locus 2. Mutation of the repressor binding site in promoter • Repressor can not bind 3. Mutations in ubiquitin binding site • Ubiquitin can not bind • Not targeted to proteasome • Can not be degraded → Continued expression on Bcl-6
57
Give an example of a drug that 'addresses the nature of the cell'
Bortezimib • Malignant plasma cells (in MM) are producing a large amount of protein • They rely on the proteasome to degrade miss-folded protein • Bortezimib prevents the proteasome from properly functioning, so the plasma cells die
58
Which mutation commonly causes DLBCL?
Bcl-6 overexpression
59
Which mutation commonly causes CLL?
Bcl-2 overexpression
60
Which mutation commonly causes follicular lymphoma?
Bcl-2 over expression
61
Which cancer is Rituximab used for?
Non-Hodgkins lymphoma
62
Describe the risk-reward balance in B cells
Risk: development of cancers Reward: very efficient way of protecting against microbes Despite the risks, B cell cancers are rare, so these processes were not removed in evolution – the benefit outweighs the risk
63
How may chromosomal translocations be identified?
Classical / outdated: • Karyotyping • FISH • Probe for myc Now: • Cancer genome sequencing
64
Describe the B cell cancer genome map
Based on new sequencing technologies, many of the common (and not so common) translocations that can lead to B cell cancers have been identified Important loci: • IgH, IgK, IgL • Bcl2, Myc, Bcl6 These loci are fused together
65
Describe regulation of the cell cycle
Drivers: • Cyclins • Transiently expressed • Phosphorylate Cdks Brakes: • p21, p15, p18 • Bind Cdks to inhibit their activity Activated Cdks phosphorylate Rb
66
What is the general function of Bax and Bak?
Pro-apoptotic
67
Compare Ig content of blood in healthy individuals with those with MM
Normal: • 10-15 mg/ml • Heterogeneous MM: • 30 mg/ml • Clonal